HealthLeaders Media January 11, 2023
Lowering the cost of prescription drugs is a key component of the Inflation Reduction Act.
KEY TAKEAWAYS
– CMS will publish the first 10 high-cost Medicare Part D drugs picked for negotiations on Sept. 1.
– The “negotiated maximum fair prices” for the drugs to be announced on Sept. 1, 2024, and the prices will take effect on Jan. 1, 2026.
– CMS will pick another 15 Part D drugs for 2027, 15 more Part B or Part D drugs for 2028, and 20 more Part B or Part D drugs for each year after that.
The federal government on Wednesday made public its timetable for the first round of its ballyhooed Medicare Drug Price Negotiation Program.
In a conference...